Nymox Pharmaceutical Corp
NYMXF
Revenue
0.00
0.000.00%
12 Months ChangeAssets
654.00k
▲30.00k▲4.81%
3 Months ChangeLiabilities
7.43M
▲509.00k▲7.36%
3 Months ChangeFree Cash Flow
-991.00k
▲3.22M▲76.44%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-29
Form 20-F
ID: 0001640334-24-001383
2023-05-02
Form 20-F
ID: 0001640334-23-000736
2022-03-30
Form 20-F
ID: 0001640334-22-000622
2021-03-29
Form 20-F
ID: 0001640334-21-000680
2020-03-30
Form 20-F
ID: 0001640334-20-000668
2019-03-29
Form 20-F
ID: 0001640334-19-000464
2018-03-30
Form 20-F
ID: 0001640334-18-000561
2017-03-31
Form 20-F
ID: 0001176256-17-000083
2016-03-31
Form 20-F
ID: 0001176256-16-000495
2015-03-31
Form 20-F
ID: 0001176256-15-000122